Medtronic Q1 Revenues Fall 4% On Decreased Hospital Utilization
This article was originally published in The Gray Sheet
Executive Summary
Medtronic is blaming a 4% decline in corporate first quarter sales on worsening hospital utilization rates in the U.S. The businesses most affected were Cardiac Rhythm Disease Management and Spine, CEO Bill Hawkins reported during an Aug. 24 earnings call
You may also be interested in...
Device Firms Should Get Used To Lower Growth Rates, Analyst Says
Growth rates for device use declined precipitously last quarter, and the industry should be prepared for a slow recovery, say Morgan Stanley device sector analysts. What's more, pre-2009 growth rates may be out of reach in the foreseeable future
Device Firms Should Get Used To Lower Growth Rates, Analyst Says
Growth rates for device use declined precipitously last quarter, and the industry should be prepared for a slow recovery, say Morgan Stanley device sector analysts. What's more, pre-2009 growth rates may be out of reach in the foreseeable future
Medtronic Expands Ortho Biologics Presence With Osteotech Acquisition
Medtronic is shoring up its orthopedic biologics business through the acquisition of demineralized bone matrix marketer Osteotech for $123 million, announced Aug. 17